title: [Course of pulmonary hypertension in patients operated for rheumatic mitral heart disease].
abstract: OBJECTIVE
  To study changes in pulmonary hypertension in patients with isolated mitral valvular defects of rheumatic etiology after surgical correction and in the early postoperative period.
  
  
  METHODS
  Central hemodynamics in heart chamber probing before operation and intraoperatively were measured in 98 patients with rheumatic mitral defects (41 males, 57 females, mean age 39.5 +/- 8.74). Manometry before and after the defect correction, intraoperative catheterization (cath. Swan-Ganz) for hemodynamics 24-h follow-up were made.
  
  
  RESULTS
  After valvular defect correction 90(91%) patients had residual pulmonary hypertension, stage II-III in 41%.
  
  
  CONCLUSIONS
  Patients operated for rheumatic heart disease complicated by pulmonary hypertension often suffer from residual pulmonary hypertension. This requires pharmacological correction.
authors.forename: E V
authors.initials: EV
authors.lastname: Privalova
authors.forename: L P
authors.initials: LP
authors.lastname: Cherepenin
authors.forename: V I
authors.initials: VI
authors.lastname: Ershov
authors.forename: G M
authors.initials: GM
authors.lastname: Baloian
authors.forename: T A
authors.initials: TA
authors.lastname: Buravikhina
authors.forename: A I
authors.initials: AI
authors.lastname: Ermakov
authors.forename: A S
authors.initials: AS
authors.lastname: Ivanov
mesh_terms: D000328:Adult; D001783:Blood Flow Velocity; D001794:Blood Pressure; D006328:Cardiac Catheterization; D002404:Catheterization; D005260:Female; D006349:Heart Valve Diseases / Q000150:complications / Q000601:surgery; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology / Q000503:physiopathology*; D008297:Male; D008943:Mitral Valve; D016343:Monitoring, Intraoperative; D011652:Pulmonary Circulation; D011669:Pulmonary Wedge Pressure; D012214:Rheumatic Heart Disease / Q000150:complications / Q000601:surgery*; D016896:Treatment Outcome